Up another 10%, page-101

Pretty significant rise too in that it was looking like a descending triangle so if it broke down could have dropped 20c. Nice to see that (apparently) rejected now. Looks like it found support at around the may 26 gap up value mid 60s. Hopefully up to old highs now. Only issue I see is issue of performance shares and timing of phase 1 trial might take the shine off a bit. I would think most companies announce trwill ial possibly 3 months out not 6. Hopefully they do have it all definately locked in and ready to start as promised, as if nothing else eventuate I guess that is next big test. I Will be nervous waiting to see how first patients react to iv dose, assuming that is what is planned.